Zebra Technologies Selects TCS to Help Drive IT Agile Transformation and DevSecOps Services
Tata Consultancy Services (TCS) (BSE: 532540, NSE: TCS), a leading global IT services, consulting, and business solutions organization, announced a strategic transformation engagement with Zebra Technologies Corporation (NASDAQ: ZBRA), a market leader in industry-tailored solutions that make every front-line worker and asset at the edge visible, connected and fully optimized.
Zebra provides an award-winning portfolio of purpose-built hardware, software, services, and solutions that digitize and automate workflows for the retail, manufacturing, transportation and logistics, supply chain, healthcare, and government sectors. It selected TCS to help drive its IT Agile transformation and provide DevSecOps services to continue its focus on innovation. With its contextual knowledge and industry expertise, TCS will play a key role in the end-to-end global agile transformation of Zebra’s IT that supports its systems and applications used by 8,800 employees in 45 countries.
Leveraging automation and artificial intelligence, TCS will incorporate even higher levels of intelligent automation for quicker resolution of issues and an enhanced user experience. The transformed IT operating model will be leaner, more agile, and will support changing business models.
TCS will accelerate Zebra’s adoption of a DevSecOps model across applications, infrastructure, and security services, making the new IT landscape more resilient, secure, and agile. Additionally, TCS will collaborate with Zebra’s IT Innovation Council to identify opportunities for additional innovation with intelligent technologies and for speed-to-market
"Zebra has been at the forefront of enterprise asset intelligence used in numerous industries, and this agile transformation of our IT operating model supports the company’s growth and transformation objectives to help extend our leadership position,” said Deepak Kaul, Chief Information Officer, Zebra Technology. “We look forward to working with TCS on the global deployment of an intelligent automation and DevSecOps IT operating model to become even more agile and value driven."
"The events over the last 20 months have been a catalyst to companies giving greater importance to enterprise agility and security,” said V Rajanna, Global Head, Technology Business Unit, TCS. “We are delighted to further deepen our relationship with Zebra in this strategic transformation. The new resilient digital core will be better aligned with their business strategy in supporting their future growth."
TCS has worked with Zebra Technologies since 2015, providing a range of services including IT, infrastructure, cybersecurity operations, and product engineering. In recent years, TCS has supported initiatives in embracing digital technologies to reimagine customer and partner experiences. In 2020, TCS helped implement a unified ecommerce platform that offers Zebra partners self-service capabilities, product recommendations and region-specific catalogs.
Winners of the Infosys Finacle Banking Innovation Awards 2021 Announced
Infosys Finacle, part of EdgeVerve Systems, a wholly-owned subsidiary of Infosys (NSE, BSE, NYSE: INFY), today announced the winners of the annual Infosys Finacle Innovation Awards 2021. Close to 270 nominations were received from 50 banks globally, across ten award categories. An expert jury comprising global banking and technology leaders evaluated the nominations based on Innovation Quotient, Benefit Quotient and Complexity Quotient, to decide the winners. In its seventh edition, the award program recognized financial institutions across the world, for breakthrough innovations and novel approaches that create new value for their stakeholders
nfosys Finacle Innovation Awards 2021 recognized initiatives that impacted the banking business across ten award categories - Product Innovation, Channel Innovation, Customer Journey Reimagination, Corporate Banking Digitization, Ecosystem-led Innovation, Process Innovation, Transformation Excellence, Modern Technologies-led Innovation, Business Model Innovation, and COVID Response Innovation. Given the backdrop of the global pandemic, the categories of Business Model and COVID Response Innovation, were newly introduced this year, reflecting the emergent operational and innovation demand on banks.
Commenting on the innovations nominated for the awards program, Sanat Rao, Chief Business Officer and Global Head, Infosys Finacle, said, “We are living in times of unprecedented change. An era that demands relentless customer-centric innovation to stay competitive and relevant. The Covid-19 pandemic has further pushed the situation into overdrive, forcing banks to embrace innovative business models, drive customer-centric value streams, and scale organizational capabilities for the digital era. The nominees and winners in the Infosys Finacle Innovation Awards 2021 clearly display efforts in this direction, creating some of the most impactful technology-led banking innovations around the world. The scale and variety of nominations this year indicate the sustained investment and focus on innovation by banks worldwide. My heartiest congratulations to all the recognized banks, and I wish them continued success in 2021 and beyond.”
John Carroll, Head of International and Transactional Banking, Santander UK, said, “Santander Global Connect allows us to help UK businesses of all sizes to seamlessly manage their international transaction and cash management banking needs, as well as to develop and grow relationships with existing customers and support the international growth needs of new customers. There has never been a more important and exciting time for businesses to consider international expansion. The tool is crucial to assist both customers and our own international banking strategy, now and in the future
Ravindra Pandey, Deputy Managing Director & Chief Information Officer, State Bank of India, Global IT Centre, said, “State Bank of India is proud of having launched uniform, user-friendly and feature-rich yono Global Mobile Banking application for the customers of SBI’s international operations, in eight countries so far. The technology change has already started globally where everything is evolving around mobility and mobile and Internet are becoming intrinsic part of our daily routine. We thank our tech partner, Infosys Finacle, for having converted our digital vision into reality. We are sure that our yono Global mobile application will meet our customers’ expectations of ‘Banking on the Go’ with ease and convenience.”
Anton Nicolaisen, Chief Executive, Standard Lesotho Bank, said, “Our future is towards being every person’s platform of choice that offers more than just financial services. This future-ready state requires technology that fuels innovation and ensures our services are safe, reliable, and convenient. Our innovation strategy puts our clients at the center of everything that we do, enabled by technology platforms, data environment, ecosystems, partnerships, and the workforce of the future. The cloud-native Infosys Finacle universal banking solution is therefore significant for the success of our strategy.”
HCL Technologies to Enhance Euroclear’s Digital Landscape
HCL Technologies (HCL), a leading global technology company, announced a new multi-year application deal with Euroclear Group to accelerate its agile transformation journey with technologies and working practices to improve its digital capabilities
HCL will work with Euroclear, the world's largest provider of domestic and cross-border settlement and related services for bond, equity and fund transactions, to explore new business models and market opportunities to create value through innovation and data monetization. Leveraging its Fenix 2.0 execution framework, HCL will modernize Euroclear’s digital channel landscape. This will help Euroclear accelerate innovation in its digital channels by harnessing automation, unified end-customer experience and DevOps delivery models.
Capitalizing on its deep-domain knowledge and vast experience of driving transformation with other financial services clients, HCL will establish a co-innovation lab in Brussels, where it will work with Euroclear on sustainable innovation to answer market problems and new digital initiatives that drive business value. The lab will create an entrepreneurial environment to explore emerging technologies and trends, and apply them to create new products and services.
“We’re delighted Euroclear selected HCL to become its strategic partner in such a visionary transformation,” said Sudip Lahiri, Senior Vice President and Head of Financial Services, Europe, HCL Technologies. “This deal is a great endorsement of HCL’s proven experience delivering value for our clients by co-creating new services and harnessing data to drive innovation and diversification. Our partnership-driven approach will foster a culture of continuous improvement for Euroclear’s business.”
Glenmark Pharmaceuticals makes it to the prestigious Dow Jones Sustainability Emerging Markets Index for the fourth consecutive year
Dow Jones Sustainability Index is one of the world’s premier benchmarks for sustainable
business practices
Glenmark is among only 15 companies from India and one of the five companies from
the Pharmaceuticals, Biotechnology & Life Sciences sector, to be listed in the DJSI
Emerging Markets Index this year
Glenmark Pharmaceuticals Ltd. (Glenmark), a research-led global integrated pharmaceutical company, today announced that the company has been listed in the Dow Jones Sustainability Index (DJSI), under the category of emerging markets for the fourth consecutive year. DJSI is one of the world’s most respected and widely accepted sustainability benchmarks globally with only the top ranked companies in terms of Corporate Sustainability within each industry featured in the index.
The DJSI analyses companies on their corporate economic, environmental and social performance, to assess issues such as but not limited to corporate governance, risk management, environmental policy & management systems, supply chain management, occupational health and safety, labor practices, innovation and cyber security amongst others. Inclusion in this list is considered highly prestigious by global investors, financial analysts and other stakeholders and serves as a benchmark for investors who integrate sustainability considerations into their portfolios
“Our inclusion in the coveted Dow Jones Sustainability Indices (DJSI) for the fourth consecutive year, is a validation of our commitment to sustainability and reiterates our consistent performance across all sustainability indicators. The DJSI inclusion strengthens our resolve to uphold our sustainability strategy that encompasses the Environmental, Social and Governance (ESG) principles to make a positive difference to our operations, stakeholders, communities and the planet at large,” said Glenn Saldanha, Chairman and Managing Director, Glenmark Pharmaceuticals
Over 800 companies across sectors from the emerging markets were assessed, out of which around 108 made it to the prestigious index this year including 15 from India. Glenmark is one of the only five companies from the Pharmaceuticals, Biotechnology & Life Sciences sector to be featured in the DJSI Emerging Markets 2021.
Genesys International grows its strategic expertise with a new Advisory Board
Genesys International Corporation Limited, headquartered in Mumbai, has announced the constitution of an Advisory Board. The appointment of the these key experts as part of their organization has been made with a vision to enhance the strategic business and technical capabilities as it embarks upon building its significant map content initiatives.
The newly appointed advisory board comprises –
1. Mr. Paul Smith, an internationally recognised geospatial leader. Co founder of Earth
Observant [EOI] which is revolutionizing remote sensing through a disruptive new
satellite platform delivering ultra-high resolution, analysis-ready earth observation data
for machine learning and traditional image-analyst applications. Paul has been
instrumental in marquee map content/technologies in the companies he has been
involved with such as C3 technologies, an imaging platform sold to Apple, and
Earthmine bought by Nokia (Here maps). He was also a key part of the Hexagon content
program. Mr. Paul has expertise in location-based technologies and geo content from
street views to satellite imagery. Mr. Paul has negotiated and partnered with the world's
leading organizations in web mapping, local search, real estate, and consumer
navigation to name a few.
2. Major General (Dr) B Nagarajan is the pioneer in the field of developing Cadastre based land Information System. He has been awarded the National Geomatics Award for Applications in 2008 by the Indian Society of Geomatics. He was the additional Surveyor General of India and has initiated path breaking initiatives such as ‘Redefinition of Indian Geodetic datums - Horizontal and Vertical’ with the generation of a new geocentric coordinate system, which would replace the 175 years old locally best fitting Everest coordinate system, in the field of topographical mapping. He has redefined the Indian vertical datum based on geopotential numbers completing more than 46,000 linear kilometers of high precision levelling along with gravity observations in a span of just 2 years.
Commenting on the formulation of the Advisory Board, Mr. Sajid Malik, CMD, Genesys International Corporation Limited said, “We welcome aboard Mr. Paul Smith and Major General (Dr) B Nagarajan as part of the Advisory Board. At Genesys International we have always strived to create distinct benchmarks in the geospatial sector with the technology at hand. In addition to this, the expertise of this Advisory Board will greatly leverage the pan India content program of Genesys“
Further commenting on this, Paul Smith said, “I am very excited about the Genesys India map program and the capabilities that they have built in the geospatial content space. I believe India promises to be one of the largest geo markets as its economy grows and the new policy allows for geotech to be used. Genesys is well positioned to be a leader in this emerging sector.“
In recent months, owing to the positive support extended by the Government through varied policy announcements, the geospatial industry is poised for rapid development. Thus investments made by Genesys International in Indian geospatial content and survey infrastructure will hold good in the future
Biocon Biologics and Viatris Announce Launch of Interchangeable SEMGLEE® (insulin glargine-yfgn) Injection and Insulin Glargine (insulin glargine-yfgn) Injection
Branded and unbranded versions of the first-ever interchangeable biosimilar in the U.S. provide more affordable options for the millions of Americans living with diabetes
Biocon Biologics Ltd., a subsidiary of Biocon Ltd., and Viatris Inc. (NASDAQ: VTRS) today announced the U.S. launch of interchangeable biosimilars SEMGLEE® (insulin glargineyfgn) injection, a branded product, and Insulin Glargine (insulin glargine-yfgn) injection, an unbranded product, to help control high blood sugar in adult and pediatric patients with type 1 diabetes and adults with type 2 diabetes. Both biosimilar products are available in vial and prefilled pen presentations and are interchangeable for the reference brand, LANTUS® (insulin glargine), allowing for substitution at the pharmacy counter.
Shreehas Tambe, Deputy CEO, Biocon Biologics said: “At Biocon Biologics we are committed to expanding access to high-quality, affordable biologics to patients worldwide. The launch of our interchangeable biosimilar insulin glargine in the U.S. by our partner Viatris is in line with our aspiration to provide our biosimilar insulins to ‘one in five’ insulin dependent people with diabetes, globally. This is indeed a landmark event and along with the recent formulary listings, we believe it will allow us to improve accessibility, availability and adoption of biosimilars in the U.S. for the benefit of patients and the overall healthcare system.”
Viatris Head of North America Jose Cotarelo said: “Viatris has a long-standing commitment to improving patient access to sustainable, quality and more affordable healthcare. We are extremely proud to stay true to that promise by bringing to millions of people with diabetes these interchangeable insulin biosimilar treatment options. We are pleased to also offer a broad range of options to help patients, which are intended to maximize access to these important medicines, regardless of financial circumstances, insurance or channel.” SEMGLEE (insulin glargine-yfgn) and Insulin Glargine (insulin glargine-yfgn), co-developed by Biocon Biologics and Viatris, are now available in the U.S. market. The currently marketed non-interchangeable SEMGLEE (insulin glargine) is anticipated to be phased out by the end of the 2021 calendar year